Cochlear Limited (ASX:COH – Get Free Report) insider Richard Freudenstein purchased 485 shares of the business’s stock in a transaction on Monday, February 16th. The shares were acquired at an average price of A$203.61 per share, for a total transaction of A$98,749.88.
Cochlear Price Performance
The firm has a market cap of $19.88 billion, a price-to-earnings ratio of 55.90, a P/E/G ratio of 3.87 and a beta of 0.47. The company has a current ratio of 2.30, a quick ratio of 1.93 and a debt-to-equity ratio of 13.24.
Cochlear Dividend Announcement
The business also recently declared a Interim dividend, which will be paid on Sunday, April 12th. Shareholders of record on Sunday, April 12th will be issued a dividend of $2.15 per share. The ex-dividend date is Wednesday, March 18th. This represents a yield of 107.0%. Cochlear’s dividend payout ratio is 77.35%.
Cochlear Company Profile
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. The company was founded in 1981 and is headquartered in Sydney, Australia.
See Also
- Five stocks we like better than Cochlear
- Your Bank Account Is No Longer Safe
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
- New gold price target
Receive News & Ratings for Cochlear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cochlear and related companies with MarketBeat.com's FREE daily email newsletter.
